1. Overview
1.1. Market Definition and Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions For the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Drivers
4.2.1.1.1. Rising Prevalence of Tuberculosis in LMICs
4.2.1.1.2. Emergence of Drug Resistant Strains
4.2.1.1.3. Favorable Initiatives for TB Diagnosis and Treatment
4.2.1.2. Restraints
4.2.1.2.1. Problems Associated with TB Testing
4.2.1.2.1.1. False Positives
4.2.1.2.1.2. Delays in Test Results Due to Delay in Immune Reaction
4.2.1.2.1.3. Poor Sensitivity of Tests
4.2.1.3. Opportunities
4.2.1.3.1. Initiatives by Governments and Organizations to Raise Awareness Regarding Tuberculosis
4.2.1.4. Challenges
4.2.1.4.1. Stigma Associated Regarding TB Patients
4.3. Trends
4.3.1. Emergence of Point-of-Care Testing
4.3.2. Biomarker Research for TB
4.4. Regulatory Analysis
4.5. Porters Five Forces Analysis
4.6. Product Pipeline Analysis
4.7. Fundings & Investment Analysis
5. Tuberculosis Diagnostics Market Assessment—by Test Type
5.1. Overview
5.2. Skin Test/Mantoux
5.3. Interferon Gamma Release Assay
5.4. Radiographic Tests
5.4.1. Chest X-rays
5.4.2. Computed Tomography
5.5. Molecular Tests
5.5.1. Rapid Diagnostic Tests
5.5.2. Whole Genome Sequencing
5.5.3. Nucleic Acid Amplification Test
5.5.4. Other Molecular Tests
5.6. Sputum Smear Microscopy
5.7. Culture & Drug Resistance
5.8. Other Test Types
6. Tuberculosis Diagnostics Market Assessment—by Infection Stage
6.1. Overview
6.2. Active
6.3. Latent
7. Tuberculosis Diagnostics Market Assessment—by End User
7.1. Overview
7.2. Diagnostic Laboratories
7.3. Hospitals & Clinics
7.4. Academic & Research Institutes
7.5. Other End Users
8. Tuberculosis Diagnostics Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Indonesia
8.4.5. Thailand
8.4.6. Philippines
8.4.7. South Korea
8.4.8. Singapore
8.4.9. Australia
8.4.10. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East
8.7. Africa
8.7.1. South Africa
8.7.2. Nigeria
8.7.3. Kenya
8.7.4. Rest of Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Ranking, by Key Players (2023)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. F. Hoffmann-La Roche Ltd.
10.2. Becton, Dickinson and Company
10.3. Abbott Laboratories, Inc.
10.4. Thermo Fisher Scientific, Inc.
10.5. QIAGEN GmbH
10.6. Hologic, Inc.
10.7. bioMérieux SA (France)
10.8. Danaher Corporation
10.9 Oxford Immunotec Ltd. (U.K.)
10.10. Hain Lifescience GmbH
10.11. Creative Diagnostics
(Note: SWOT analysis of the top 5 companies will be provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 2 Global Tuberculosis Skin Test Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Tuberculosis Interferon Gamma Release Assay Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 5 Global Tuberculosis Chest X-ray Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Tuberculosis Computed Tomography Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Molecular Tests Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 9 Global Rapid Diagnostic Tests Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Whole-genome Sequencing Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Nucleic Acid Amplification Test Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Other Molecular Tests Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Sputum Smear Microscopy Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Culture & Drug Resistance Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Other Test Types Market for Tuberculosis, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 17 Global Active Tuberculosis Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Latent Tuberculosis Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 20 Global Tuberculosis Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Tuberculosis Diagnostics Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Tuberculosis Diagnostics Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Contract Manufacturing Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Tuberculosis Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 25 North America: Tuberculosis Diagnostics Market, by Country, 2022–2031 (USD Million)
Table 26 North America: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 27 North America: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 28 North America: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 29 North America: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 30 North America: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 31 U.S.: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 32 U.S.: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 33 U.S.: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 34 U.S.: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 35 U.S.: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 36 Canada: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 37 Canada: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 38 Canada: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 39 Canada: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 40 Canada: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 41 Europe: Tuberculosis Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 42 Europe: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 43 Europe: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 44 Europe: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 45 Europe: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 46 Europe: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 47 Germany: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 48 Germany: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 49 Germany: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 50 Germany: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 51 Germany: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 52 France: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 53 France: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 54 France: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 55 France: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 56 France: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 57 U.K.: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 58 U.K.: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 59 U.K.: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 60 U.K.: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 61 U.K.: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 62 Italy: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 63 Italy: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 64 Italy: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 65 Italy: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 66 Italy: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 67 Spain: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 68 Spain: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 69 Spain: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 70 Spain: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 71 Spain: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 72 Rest of Europe: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 73 Rest of Europe: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 74 Rest of Europe: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 75 Rest of Europe: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 76 Rest of Europe: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 77 Asia-Pacific: Tuberculosis Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 78 Asia-Pacific: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 79 Asia-Pacific: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 80 Asia-Pacific: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 81 Asia-Pacific: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 82 Asia-Pacific: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 83 China: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 84 China: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 85 China: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 86 China: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 87 China: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 88 India: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 89 India: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 90 India: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 91 India: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 92 India: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 93 Japan: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 94 Japan: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 95 Japan: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 96 Japan: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 97 Japan: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 98 Indonesia: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 99 Indonesia: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 100 Indonesia: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 101 Indonesia: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 102 Indonesia: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 103 Thailand: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 104 Thailand: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 105 Thailand: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 106 Thailand: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 107 Thailand: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 108 Philippines: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 109 Philippines: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 110 Philippines: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 111 Philippines: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 112 Philippines: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 113 South Korea: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 114 South Korea: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 115 South Korea: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 116 South Korea: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 117 South Korea: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 118 Singapore: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 119 Singapore: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 120 Singapore: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 121 Singapore: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 122 Singapore: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 123 Australia: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 124 Australia: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 125 Australia: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 126 Australia: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 127 Australia: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 128 Rest of Asia-Pacific: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 129 Rest of Asia-Pacific: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 130 Rest of Asia-Pacific: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 131 Rest of Asia-Pacific: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 132 Rest of Asia-Pacific: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 133 Latin America: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 134 Latin America: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 135 Latin America: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 136 Latin America: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 137 Latin America: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 138 Middle East: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 139 Middle East: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 140 Middle East: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 141 Middle East: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 142 Middle East: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 143 Africa: Tuberculosis Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 144 Africa: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 145 Africa: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 146 Africa: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 147 Africa: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 148 Africa: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 149 South Africa: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 150 South Africa: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 151 South Africa: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 152 South Africa: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 153 South Africa: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 154 Nigeria: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 155 Nigeria: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 156 Nigeria: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 157 Nigeria: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 158 Nigeria: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 159 Kenya: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 160 Kenya: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 161 Kenya: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 162 Kenya: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 163 Kenya: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 164 Rest of Africa: Tuberculosis Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 165 Rest of Africa: Tuberculosis Radiographic Tests Market, by Type, 2022–2031 (USD Million)
Table 166 Rest of Africa: Molecular Tests Market for Tuberculosis, by Type, 2022–2031 (USD Million)
Table 167 Rest of Africa: Tuberculosis Diagnostics Market, by Infection Stage, 2022–2031 (USD Million)
Table 168 Rest of Africa: Tuberculosis Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 169 Recent Developments, by Company, 2021-2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Tuberculosis Diagnostics Market, by Test Type, 2024 Vs.2031 (USD Million)
Figure 8 Global Tuberculosis Diagnostics Market, by Infection Stage, 2024 Vs.2031 (USD Million)
Figure 9 Global Tuberculosis Diagnostics Market, by End User, 2024 Vs.2031 (USD Million)
Figure 10 Global Tuberculosis Diagnostics Market, by Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 Global Tuberculosis Diagnostics Market, by Test Type, 2024 Vs.2031 (USD Million)
Figure 13 Global Tuberculosis Diagnostics Market, by Infection Stage, 2024 Vs.2031 (USD Million)
Figure 14 Global Tuberculosis Diagnostics Market, by End User, 2024 Vs.2031 (USD Million)
Figure 15 North America: Tuberculosis Diagnostics Market Snapshot
Figure 16 Europe: Tuberculosis Diagnostics Market Snapshot
Figure 17 Asia-Pacific: Tuberculosis Diagnostics Market Snapshot
Figure 18 Africa: Tuberculosis Diagnostics Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players (2021–2024)
Figure 20 Tuberculosis Diagnostics Market: Competitive Benchmarking, by Application
Figure 21 Tuberculosis Diagnostics Market: Competitive Benchmarking, by Region
Figure 22 Competitive Dashboard Tuberculosis Diagnostics Market
Figure 23 Global Tuberculosis Diagnostics Market Share/Market Ranking Analysis, by Key Players, 2023
Figure 24 F. Hoffmann-La Roche Ltd..: Financial Overview (2023)
Figure 25 Becton, Dickinson and Company.: Financial Overview (2023)
Figure 26 Abbott Laboratories, Inc.: Financial Overview (2023)
Figure 27 Thermo Fisher Scientific, Inc.: Financial Overview (2023)
Figure 28 QIAGEN GmbH: Financial Overview (2023)
Figure 29 Hologic, Inc.: Financial Overview (2023)
Figure 30 bioMérieux SA: Financial Overview (2023)